n-acetyllactosamine has been researched along with Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Boer, RA; Frenay, AR; López-Andrés, N; Ruifrok, WP; Silljé, HH; van der Velde, AR; van Goor, H; Vreeswijk-Baudoin, I; Yu, L | 1 |
1 other study(ies) available for n-acetyllactosamine and Kidney Diseases
| Article | Year |
|---|---|
Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.
Topics: Amino Sugars; Animals; Drug Evaluation, Preclinical; Galectin 3; Hypertension; Kidney Diseases; Male; Rats, Sprague-Dawley | 2015 |